Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The ins and outs of SARS-CoV-2 variants of concern (VOCs)
Mostafa Salehi‐Vaziri, Mehdi Fazlalipour, Seyed Mahmood Seyed Khorrami, et al.
Archives of Virology (2022) Vol. 167, Iss. 2, pp. 327-344
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Prevalence of mental health conditions and brain fog in people with long COVID: A systematic review and meta-analysis
Christina M. van der Feltz‐Cornelis, Fidan Türk, Jennifer Sweetman, et al.
General Hospital Psychiatry (2024) Vol. 88, pp. 10-22
Open Access | Times Cited: 27
Understanding Mutations in Human SARS-CoV-2 Spike Glycoprotein: A Systematic Review & Meta-Analysis
Reetesh Kumar, Yogesh Srivastava, Pandiyan Muthuramalingam, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 856-856
Open Access | Times Cited: 30
Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City
Alberto Cedro‐Tanda, Laura Gómez-Romero, Guillermo de Anda‐Jáuregui, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 545-545
Open Access | Times Cited: 30
SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?
Sheeba Saifi, Varsha Ravi, Sparsh Sharma, et al.
Genomics (2022) Vol. 114, Iss. 5, pp. 110466-110466
Open Access | Times Cited: 29
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico
Marcela Peña‐Rodríguez, Jorge Hernández‐Bello, Natali Vega‐Magaña, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 19
Computational Protein Design for COVID-19 Research and Emerging Therapeutics
Parismita Kalita, Timir Tripathi, Aditya K. Padhi
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 602-613
Open Access | Times Cited: 15
Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT)
Alexis Dorta‐Gorrín, Jesús Navas, Mónica Gozalo-Margüello, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10233-10233
Open Access | Times Cited: 14
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 5
Neural networks optimization via Gauss–Newton based QR factorization on SARS-CoV-2 variant classification
Mohammad Jamhuri, Mohammad Isa Irawan, Imam Mukhlash, et al.
Systems and Soft Computing (2025) Vol. 7, pp. 200195-200195
Open Access
Rapid and Sensitive Detection of Mutations in SARS-CoV-2 by Surface-Enhanced Raman Spectroscopy
Liping Chen, Xuanjiang Zeng, Fan Yang, et al.
Langmuir (2025) Vol. 41, Iss. 5, pp. 3583-3591
Closed Access
Identification of Significant Mutations in Spike Protein of SARS‐CoV‐2 Variants of Concern and the Discovery of Potent Inhibitors
Mohsen Almakrami, Mohammed Bazuqamah, Mohammed A. Alshehri, et al.
Global Health (2025) Vol. 2025, Iss. 1
Open Access
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2
Adriano Taddeo, Inês Berenguer Veiga, Christelle Devisme, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern
Andreas C. Chrysostomou, Bram Vrancken, Christos Haralambous, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 108-108
Open Access | Times Cited: 15
Omicron-BA.1 Dispersion Rates in Mexico Varied According to the Regional Epidemic Patterns and the Diversity of Local Delta Subvariants
Selene Zárate, Blanca Taboada, Mauricio Rosales-Rivera, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 243-243
Open Access | Times Cited: 8
Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection
Laura Sánchez-de Prada, Ana María Martínez-García, Belén González-Fernández, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Clinical prediction models in hospitalized patients with COVID-19: A multicenter cohort study
Maria Cristina Vedovati, Greta Barbieri, Chiara Urbini, et al.
Respiratory Medicine (2022) Vol. 202, pp. 106954-106954
Open Access | Times Cited: 12
The importance of equally accessible genomic surveillance in the age of pandemics
Safia Zeghbib, Gábor Kemenesi, Ferenc Jakab
Biologia Futura (2023) Vol. 74, Iss. 1-2, pp. 81-89
Open Access | Times Cited: 5
Novel receptor, mutation, vaccine, and establishment of coping mode for SARS-CoV-2: current status and future
Zhaomu Zeng, Xiuchao Geng, Xichao Wen, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals
Tatjana Vilibić‐Čavlek, Vladimir Stevanović, Snježana Kovač, et al.
Antibodies (2023) Vol. 12, Iss. 4, pp. 61-61
Open Access | Times Cited: 4
Comparison of a Multiplex Real-Time PCR Technique with Oxford Nanopore Technologies Next-Generation Sequencing for Identification of SARS-CoV-2 Variants of Concern
Zahra Ahmadi, Ali Maleki, Sana Eybpoosh, et al.
Intervirology (2023) Vol. 66, Iss. 1, pp. 136-141
Open Access | Times Cited: 4
Lessons from COVID-19 Pandemic: A Successful Policy and Practice by Pasteur Institute of Iran
Mona Sadat Larijani, Alireza Biglari, Rahim Sorouri, et al.
Deleted Journal (2024) Vol. 28, Iss. 1, pp. 1-7
Open Access | Times Cited: 1
Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies
Reham F. Barghash, Donato Gemmati, Ahmed M. Awad, et al.
Molecules (2024) Vol. 29, Iss. 23, pp. 5564-5564
Open Access | Times Cited: 1
Prerequisite for COVID-19 Prediction: A Review on Factors Affecting the Infection Rate
Shirley Gee Hoon Tang, Muhamad Haziq Hasnul Hadi, Siti Rosilah Arsad, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 12997-12997
Open Access | Times Cited: 7
Early genomic, epidemiological, and clinical description of the SARS-CoV-2 Omicron variant in Mexico City
Alberto Cedro‐Tanda, Laura Gómez-Romero, Guillermo de Anda‐Jáuregui, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicron) reveals changes in the coding potential of miRNAs and their target genes
Sandeep Saini, Savi Khurana, Dikshant Saini, et al.
Gene (2022) Vol. 853, pp. 147097-147097
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top